OAM
PBYI icon

Oxford Asset Management’s Puma Biotechnology PBYI Stock Holding History

Oxford Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,647
Closed -$52.2K – 709
2025
Q1 		$52.2K Sell
17,647
-5,837
-25% -$18.3K 0.02% 451
2024
Q4 		$71.6K Buy
+23,484
New +$68.3K 0.03% 412
2024
Q3 		– Sell
-21,007
Closed -$68.5K – 419
2024
Q2 		$68.5K Buy
+21,007
New +$92.2K 0.07% 256
2020
Q1 		– Sell
-232,128
Closed -$2.03M – 980
2019
Q4 		$2.03M Buy
232,128
+98,159
+73% +$813K 0.06% 410
2019
Q3 		$1.44M Buy
133,969
+114,026
+572% +$1.23M 0.03% 736
2019
Q2 		$253K Buy
19,943
+2,543
+15% +$58.6K 0.01% 1495
2019
Q1 		$675K Buy
+17,400
New +$531K 0.01% 1099
2018
Q1 		– Sell
-4,977
Closed -$494K – 1827
2017
Q4 		$494K Buy
+4,977
New +$557K 0.01% 1183
2017
Q2 		– Sell
-22,131
Closed -$823K – 1646
2017
Q1 		$823K Sell
22,131
-28,104
-56% -$1.03M 0.02% 878
2016
Q4 		$1.54M Sell
50,235
-13,732
-21% -$594K 0.05% 388
2016
Q3 		$4.29M Buy
+63,967
New +$3.23M 0.13% 175
2016
Q1 		– Sell
-73,142
Closed -$5.71M – 867
2015
Q4 		$5.71M Buy
+73,142
New +$5.74M 0.13% 154
2014
Q2 		– Sell
-26,120
Closed -$2.72M – 754
2014
Q1 		$2.72M Buy
+26,120
New +$3.07M 0.08% 306
2013
Q3 		– Sell
-83,458
Closed -$3.7M – 878
2013
Q2 		$3.7M Buy
+83,458
New +$2.94M 0.1% 332

Other funds holding PBYI

ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Oxford Asset Management's PBYI Position: Q2 2025 in Review

Oxford Asset Management sold out of Puma Biotechnology (PBYI) in Q2 2025, closing a stake of 17,647 shares — an estimated $52.2K sold.

Oxford Asset Management first reported a position in PBYI in Q2 2013 and held it in 14 quarters. The position peaked at $5.71M in Q4 2015. 121 funds tracked by Wall St. Rank hold PBYI as of Q2 2025.

  • Oxford Asset Management reported no remaining Puma Biotechnology position as of Q2 2025 after selling out during the quarter.
  • Oxford Asset Management sold 17,647 Puma Biotechnology shares in Q2 2025, an estimated $52.2K.
  • Oxford Asset Management first reported a position in Puma Biotechnology in Q2 2013 and held it in 14 quarters.
  • Oxford Asset Management's Puma Biotechnology position peaked at $5.71M in Q4 2015.
  • 121 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2025.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.